InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
PLG | Ann: Appendix 4G | 19/09/24 | 0 | 1 | |||
|
|||||||
PLG | Ann: Annual Report - Financial Year Ended 30 June 2024 | 19/09/24 | 0 | 1 | |||
|
|||||||
PLG | Ann: CNI: CNI Capital Initiatives and Business Update | 22/03/19 | 0 | 66 | |||
|
|||||||
PLG | Ann: Suspension from Official Quotation | 21/03/19 | 0 | 96 | |||
|
|||||||
PLG | Ann: Propertylink Board Changes | 20/03/19 | 0 | 77 | |||
|
|||||||
PLG | Ann: Notice of compulsory acquisition | 14/03/19 | 0 | 344 | |||
|
|||||||
PLG | News: PLG Propertylink Group Announces Appointment Of Philip Pearce As An Executive Director | 13/03/19 | 0 | 31 | |||
|
|||||||
PLG | Ann: Initial Director's Interest Notice | 13/03/19 | 0 | 56 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||